植物生物活性化合物作为阿尔茨海默氏症疾病治疗药物的现状
1Department of General Medicine, The Second Affiliated Hospital of Dalian Medical University, 116023 Dalian, Liaoning, China.
Journal of integrative neuroscience
|January 25, 2025
概括
药用植物通过准多个途径,为阿尔茨海默病 (AD) 治疗提供了一个有希望的途径. 本综述探讨了它们通过各种分子机制减轻AD的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 传统医学的传统医学.
背景情况:
- 阿尔茨海默病 (AD) 是一种流行的神经退行性疾病,其特征是认知和神经精神疾病症状.
- 目前的阿尔茨海默病治疗方法具有症状性,具有有限的疗效和显著的副作用.
- 阿尔茨海默病的发病原因仍然不完全理解,需要新的治疗策略.
研究的目的:
- 审查最近使用药用植物治疗阿尔茨海默病的进展.
- 分析这些植物性疗法的潜在分子作用机制.
- 总结现有临床证据,支持药用植物在治疗AD方面的疗效.
主要方法:
- 关于阿尔茨海默病和药用植物研究的综合文献搜索.
- 对研究药用植物对阿尔茨海默病的发病效应的分析.
- 评估分子机制,包括蛋白质聚合,氧化应激和神经炎症.
- 对临床证据的审查和活性化合物的鉴定.
主要成果:
- 药用植物通过影响多个分子标来减轻AD的潜力.
- 关键机制包括病态蛋白质生产/聚合的调节,氧化应激,神经炎症和亡.
- 有证据表明,线粒体功能,神经发生,神经传递和肠-大脑轴的调节.
结论:
- 药用植物代表了阿尔茨海默病的有希望的补充或替代治疗方法.
- 需要进一步的研究来阐明具体的机制,并确定有力的活性成分.
- 这些天然化合物提供了一种多目标策略,以解决AD病变的复杂性.
相关概念视频
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95


